• Drugs
• Medical Devices
• Food Supplements
• Advanced Therapies: gene therapy, cell therapy (e.g., Inmunotherapy, stem cells) and tissue engineering.
• Nuclear Medicine
• Radiotherapy
• Biotechnology
• Veterinary Products

Phase I:

• First studies in human
• Pharmacokinetic
• Bioequivalence (e.g., for generic drugs)
• Bioavailability (e.g., comparison of different route of administrations)
• Pharmacodynamic

Phase II:

• Proof of concept
• Dose finding
• Pilot studies

Phase III:

• Confirmation studies
• Randomized studies
• Controlled studies (e.g., gold standard, Placebo)
• Blinded studies

Phase IV:

• Safety
• Special medical problems
• Special patient populations
• Long-term experience
• Pharmacoeconomics
• Quality of Life

• Post authorization studies:
  • Prospective
  • Retrospective
  • Ambispective
  • Cross sectional
• Epidemiology studies

• Validation of scales
• Congress / meeting organization
• Advisory boards
• Training programs